MyFinsight
Home
Blog
About
Maturing in one year or
less-Corporate Debt Securities
$325,389K
(14.41%↑ Y/Y)
Maturing in one year or
less-USTreasury And Government
$165,763K
(-11.32%↓ Y/Y)
Maturing after one year
through three...
$100,902K
(49.67%↑ Y/Y)
Maturing after one year
through three...
$78,079K
(13.93%↑ Y/Y)
Marketable securities
$670,133K
(10.35%↑ Y/Y)
Cash and cash
equivalents
$47,454K
(105.93%↑ Y/Y)
Prepaid and other
current assets
$7,114K
(-60.43%↓ Y/Y)
Accounts and other
receivables
$230K
(155.56%↑ Y/Y)
Total current assets
$724,931K
(11.80%↑ Y/Y)
Intangible assets
$27,190K
(0.00%↑ Y/Y)
Other assets
$15,434K
(65.96%↑ Y/Y)
Property and equipment,
net
$9,756K
(122.13%↑ Y/Y)
Operating lease
right-of-use assets, net
$5,038K
(61.42%↑ Y/Y)
Total assets
$782,349K
(12.99%↑ Y/Y)
Total liabilities and
stockholders' equity
$782,349K
(12.99%↑ Y/Y)
Total stockholders'
equity
$714,564K
(9.03%↑ Y/Y)
Total liabilities
$67,785K
(83.20%↑ Y/Y)
Accumulated deficit
-$1,966,169K
(-18.04%↓ Y/Y)
Additional paid-in capital
$2,679,356K
(15.61%↑ Y/Y)
Total current
liabilities
$61,325K
(86.04%↑ Y/Y)
Long-term portion of
operating lease...
$3,347K
(123.88%↑ Y/Y)
Other long-term
liabilities
$3,113K
(22.41%↑ Y/Y)
Accumulated other
comprehensive income
$1,298K
(-61.13%↓ Y/Y)
Common stock, .001 par
value 297,000,000...
$79K
(19.70%↑ Y/Y)
Accrued expenses
$43,863K
(54.32%↑ Y/Y)
Accounts payable
$14,675K
(607.91%↑ Y/Y)
Current portion of
operating lease...
$1,557K
(1.37%↑ Y/Y)
Current portion of other
long-term liabilities
$1,230K
(32.26%↑ Y/Y)
Back
Back
Balance Sheet
Celldex Therapeutics, Inc. (CLDX)
Celldex Therapeutics, Inc. (CLDX)
source: myfinsight.com